Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 7, 2008 - Issue 2
Submit an article Journal homepage
256
Views
8
CrossRef citations to date
0
Altmetric
Reviews

The safety of dopamine agonists in the treatment of Parkinson's disease

Ubaldo Bonuccelli University of Pisa, Department of Neuroscience, Via Roma, 67 56100 Pisa, Italy [email protected]
&
Roberto Ceravolo University of Pisa, Department of Neuroscience, Via Roma, 67 56100 Pisa, Italy [email protected]
Pages 111-127 | Published online: 06 Mar 2008

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Michele A Faulkner. (2014) Safety overview of FDA-approved medications for the treatment of the motor symptoms of Parkinson’s disease. Expert Opinion on Drug Safety 13:8, pages 1055-1069.
Read now

Articles from other publishers (7)

Ratchaniporn Kongsui, Tichanon Promsrisuk, Lars Klimaschewski, Napatr Sriraksa, Jinatta Jittiwat & Sitthisak Thongrong. (2023) Pinostrobin mitigates neurodegeneration through an up-regulation of antioxidants and GDNF in a rat model of Parkinson’s disease. F1000Research 12, pages 846.
Crossref
Ratchaniporn Kongsui, Tichanon Promsrisuk, Lars Klimaschewski, Napatr Sriraksa, Jinatta Jittiwat & Sitthisak Thongrong. (2023) Pinostrobin mitigates neurodegeneration through an up-regulation of antioxidants and GDNF in a rat model of Parkinson’s disease. F1000Research 12, pages 846.
Crossref
Sara Redenšek, Maja Trošt & Vita Dolžan. 2018. Parkinson's Disease - Understanding Pathophysiology and Developing Therapeutic Strategies. Parkinson's Disease - Understanding Pathophysiology and Developing Therapeutic Strategies.
Shan H. Siddiqi, Natalia K. Abraham, Christopher L. Geiger, Morvarid Karimi, Joel S. Perlmutter & Kevin J. Black. (2016) The Human Experience with Intravenous Levodopa. Frontiers in Pharmacology 6.
Crossref
Clelia Pellicano, Dario Benincasa, Alessandra Fanciulli, Pamela Latino, Morena Giovannelli & Francesco E Pontieri. (2013) The impact of extended release dopamine agonists on prescribing patterns for therapy of early Parkinson’s disease: an observational study. European Journal of Medical Research 18:1.
Crossref
Michael Schachter. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions 281 294 .
I. G. Silkis. (2009) Search for approaches to correction of daytime sleepiness induced by dopaminergic drugs during treatment of Parkinson’s disease: Neurochemical aspects. Neurochemical Journal 3:3, pages 221-231.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.